19-2733012-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144564.5(SLC39A3):āc.684C>Gā(p.Asp228Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000207 in 1,447,830 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_144564.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC39A3 | NM_144564.5 | c.684C>G | p.Asp228Glu | missense_variant | 3/3 | ENST00000269740.9 | NP_653165.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC39A3 | ENST00000269740.9 | c.684C>G | p.Asp228Glu | missense_variant | 3/3 | 1 | NM_144564.5 | ENSP00000269740.3 | ||
ENSG00000267001 | ENST00000586572.1 | c.210+4036C>G | intron_variant | 4 | ENSP00000467958.1 | |||||
SLC39A3 | ENST00000545664.5 | c.684C>G | p.Asp228Glu | missense_variant | 3/4 | 2 | ENSP00000445345.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000437 AC: 1AN: 228744Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 126348
GnomAD4 exome AF: 0.00000207 AC: 3AN: 1447830Hom.: 0 Cov.: 37 AF XY: 0.00000139 AC XY: 1AN XY: 719030
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 16, 2023 | The c.684C>G (p.D228E) alteration is located in exon 3 (coding exon 2) of the SLC39A3 gene. This alteration results from a C to G substitution at nucleotide position 684, causing the aspartic acid (D) at amino acid position 228 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at